Neurocrine Biosciences | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
ALKERMES USD 1.8M 35K 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Cytokinetics USD 119K 1000 2025-03
Dynavax Technologies USD 124K 1000 2025-03
Exelixis USD 282K 4K 2025-01
Gilead Sciences USD 1000K 0 2024-12
Halozyme Therapeutics USD 123K 0 2025-03
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 481M 1000K 2025-03
Prothena USD 538K 0 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Repligen USD 562K 1000 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Neurocrine Biosciences Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.